Skip to main content
MPT logo

MPT · Medical Properties Trust Inc

Track MPT — free
Market Cap
$2.03B
Shares
598.10M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$3.40 Open$3.62 Day$3.36–3.62 52W close$3.39–6.02 Avg vol 30d10.3M Short int150.1M · 25.1% float · 20.9d Short vol70% Last earningsAug 10, 2026 DataJan 2020–Sep 2026 Filing10-Q · Aug 10

Up next

Next earnings call
Nov 15, 2026 Est · unconfirmed · in 8 wks
filed Aug 10, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.00B
Trailing 12 months
Net income (TTM)
−$126.24M
Trailing 12 months
Revenue growth YoY
+12.6%
Year over year
Operating margin
Trailing 12 months
P / E (TTM)
Trailing earnings
FCF yield
TTM · current market cap
Return on invested capital
Trailing 12 months
Net cash
−$9.24B
Latest balance sheet
Dividend yield
10.6%
Trailing 12 months
Shares change YoY
-0.5%
Year over year · fewer shares
Price change (1Y)
-32.5%
Trailing year
Short interest
25.1%
Latest settlement · 20.9 days to cover
View all 115 metrics

AI Brief

Q2 FY26 earnings call · Aug 10, 2026
Q2 FY26

TL;DR. MPT announced a $2.4 billion 9.25% secured refinancing that eliminates 2026 maturities and materially reduces 2027 unsecured maturities, with no debt due until June 2028; portfolio coverage remains broadly stable with post-acute EBITDA up over $70 million YoY and NFFO of $0.15 in line with expectations, while behavioral health coverage slipped to 1.4x and U.K. NHS funding pressure persists.

Bullish
  • + Announced $2.4 billion refinancing extends $2.4 billion of debt maturities to 2032 with no debt maturing in 2026 or 2027.
  • + Refinancing reduces total principal debt by approximately $123 million and substantially increases UA/UD covenant headroom to up to nearly 300%.
  • + Post-acute portfolio EBITDA increased more than $70 million YoY, led by 24% growth in Median and 13% in Ernest Health, with 2.4x coverage.
  • + Asset sales validate market values materially above book, including a pending $172 million sale at a 60%+ gain over original investment and 34% IRR.
Bearish
  • Behavioral health coverage slipped to 1.4x due to U.K. NHS funding pressures and is a source of pressure on the overall portfolio.
  • HSA cash collections remain below target (still in the 80s), with a Meditech EMR conversion, RCM outsourcing disruption, and delayed Florida supplemental funding pressuring liquidity.
  • Secured debt ratio is rising to near the 40% covenant ceiling, limiting additional secured-debt capacity absent asset sales.
  • Company impaired approximately $17 million in working capital loans tied to Steward replacement tenants in the Midwest.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 14.8 · calm Equity put/call 0.58
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −30%
below
Price vs 50-day avg −20%
below
RSI (14) 29
oversold
MACD trend Negative
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −17%
trailing
6-month return −25%
trailing
YTD return −32%
this year
Relative strength −45%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $4 › 200d $5 — 200d above 50d
Institutional flow Distributing
-2% holders QoQ · +52 funds added
Insider flow Accumulating
Net +$9.5K over 90 days · 0% sells
Short interest Rising
25.09% of float · ▲ +3.9% MoM · 20.9 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Steady
496 holders — mid 3-yr range
Squeeze score 66
elevated · 0–100
Fundamentals
Fair
Revenue growth −2%
Y/Y
EPS growth +89%
Y/Y
Buyback $150.0M
authorized
Balance sheet $9.2B
net debt
Quant / Vol
risk profile
Very High
Volatility 37%
annualized · 1-yr
Max drawdown −44%
past year
ATR 4.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−30% Bearish
Price vs 50-day avg
−20% Bearish
RSI (14)
29 Neutral
MACD trend
Negative Bearish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $4 › 200d $5 — 200d above 50d
Institutional flow Distributing
-2% holders QoQ · +52 funds added
Insider flow Accumulating
Net +$9.5K over 90 days · 0% sells
Short interest Rising
25.09% of float · ▲ +3.9% MoM · 20.9 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Steady
496 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $3 Now $3 · 0% Range high $6
vs 200-day avg -30% vs 50-day avg -20%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

REIT - Healthcare Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
MPT
Medical Properties Trust Inc
this stock
$2.03B -32.0% -2.4% 25.1%
WELL
Welltower Inc.
$164.51B +23.3% +35.6% 115.9 2.6%
VTR
Ventas, Inc.
$45.31B +12.0% +18.5% 163.6 4.0%
OHI
Omega Healthcare Investors Inc
$14.14B +5.2% +13.2% 16.6 4.3%
DOC
Healthpeak Properties, Inc.
$14.00B +26.4% +4.5% 58.0 3.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
496
% held
64.2%
Net QoQ
+14.7M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
253
View
Short & Settlement
Short Interest Rising
Shares short
150.1M
Days to cover
20.9d
Change
+5.6M sh
View
Short Volume
Short vol %
70%
As of
Sep 18, 2026
Short Total
View
Fails to Deliver
FTD shares
39.0K
Value
$159.5K
As of
Aug 31, 2026
View
Off-Exchange
Off-exchange %
50.1%
Week of
Aug 10, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$9.5K
Buyers / Sellers
1 / 0
Buyers Sellers
View
Congressional Trades Sell
Member
Pete Sessions
Amount
$257–$257
Traded
Nov 3, 2023
View
Financials
Financials
Revenue (FY)
$972.0M
Net income (FY)
$-277.0M
EPS diluted
$-0.46
View
Buybacks
Authorized
$150.0M
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 10, 2026
This year
10
View
Proposed Sales
Value
$300.9K
Shares
59.0K
Filed
Nov 19, 2025
View
Earnings & Events
Earnings Calls
Last call
Aug 10, 2026
View
Investor Relations
Latest news
MPT Completes the Sale of Two Hos…
Published
Sep 16, 2026
View

Performance

5D 20D 120D MTD YTD
MPT -6.6% -16.7% -24.9% -14.4% -32.0%
SPY -0.3% -0.1% +20.1% -0.7% +11.7%
vs SPY -6.3% -16.6% -45.1% -13.7% -43.7%

Capital returns

Latest dividend
$0.09 / share · ex Sep 10, 2026
Raised 12.5%
Paid (TTM)
$0.36 / share · 4 payouts
Dividend yield (TTM, derived)
10.59%
Buyback program · as of Oct 28, 2025
Authorized
$150.00M
Spent (derived)
Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1287865 CUSIP 58463J304 13F (30d) 11 filings 11 filers Visit website Investor relations